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H ypothermia is the most frequently used method toprotect the brain when antegrade flow is interrupted
during operations on the aortic arch.1 Its efficacy is lim-
ited, however, as a result of the safe duration of
hypothermic circulatory arrest (HCA) being 40 to 50
minutes at brain temperatures of 10°C to 15°C.2
Ischemic cerebral injury follows a well-attested
sequence of events including 3 phases: depolarization,
biochemical cascade, and reperfusion injury. The
importance of the failure of neurotransmitter transport
as a common pathway in the pathogenesis of many neu-
rologic disorders, including ischemic cerebral injury,
has been widely demonstrated in the past few years.3
Background: Ischemic cerebral injury follows a well-attested sequence of
events, including 3 phases: depolarization, biochemical cascade, and reper-
fusion injury. Leukocyte infiltration and cytokine-mediated inflammatory
reaction are known to play a pivotal role in the reperfusion phase. These
events exacerbate the brain injury by impairing the normal microvascular
perfusion and through the release of cytotoxic enzymes. The aim of the pre-
sent study was to determine whether a leukocyte-depleting filter
(LeukoGuard LG6, Pall Biomedical, Portsmouth, United Kingdom) could
improve the cerebral outcome after hypothermic circulatory arrest.
Methods: Twenty pigs (23-30 kg) were randomly assigned to undergo car-
diopulmonary bypass with or without a leukocyte-depleting filter before and
after a 75-minute period of hypothermic circulatory arrest at 20°C.
Electroencephalographic recovery, S-100β protein levels, and cytokine lev-
els (interleukin 1β, interleukin 8, and tumor necrosis factor α) were record-
ed up to the first postoperative day. Postoperatively, all animals were evalu-
ated daily until death or until electively being put to death on day 7 by using
a quantitative behavioral score. A postmortem histologic analysis of the
brain was carried out on all animals.
Results: The rate of mortality was 2 of 10 in the leukocyte-depletion group
and 5 of 10 in control animals. The risk for early death in control animals
was 2.5 (95% confidence interval, 0.63-10.0) times higher than that of the
leukocyte-depleted animals. The median behavioral score at day 7 was high-
er in the leukocyte-depletion group (8.5 vs 3.5; P = .04). The median of total
histopathologic score was 8.5 in the leukocyte-depletion group and 15.5 in
the control group (P = .005).
Conclusion: A leukocyte-depleting filter improves brain protection after a
prolonged period of hypothermic circulatory arrest.
(J Thorac Cardiovasc Surg 2000;120:1131-41)
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Previous studies suggest that the reperfusion phase
plays a significant role in the pathogenesis of ischemic
brain injury.1 After ischemic insult of the brain, leuko-
cyte infiltration can be detected. Blood vessels are
filled with leukocytes (primarily neutrophils), and
edema will develop. Leukocyte adhesion to the wall of
blood vessels and infiltration of leukocytes into
ischemic brain tissue activates an inflammatory reac-
tion that is driven by cytokines. Impaired microvascu-
lar perfusion and release of cytotoxic enzymes are
involved in inflammatory reaction, exacerbating neu-
ronal injury.4-6
Leukocyte depletion is demonstrated to mitigate
reperfusion injury after myocardial injury.7-9 Leukocyte
depletion during and after cardiopulmonary bypass
(CPB) was also found to improve pulmonary function10
and to ameliorate lung injury mediated by free radi-
cals.11,12 We have been studying the possible means to
improve the safety of HCA with a surviving porcine
model.13-15 The specific purpose of the current study
was to find out whether leukocyte depletion by filtra-
tion (Leukoguard LG6; Pall Biomedical, Portsmouth,
United Kingdom) could mitigate ischemic brain injury
and improve neurologic and neuropathologic outcomes
after HCA.
Materials and methods
Twenty female juvenile (8-10 weeks) pigs of a native stock,
weighing 23 to 30 kg, were randomly assigned to undergo
CPB with or without a leukocyte-depleting filter (L-DF)
before and after a 75-minute period of HCA at 20°C.
Preoperative management. All animals received humane
care in accordance with the “Principles of Laboratory Animal
Care” formulated by the National Society for Medical
Research and the “Guide for the Care and Use of Laboratory
Animals” prepared by the Institute of Laboratory Animal
Resources and published by the National Institutes of Health
(National Institutes of Health publication No. 85-23, revised
1985). The study was approved by the Research Animal Care
and Use Committee of the University of Oulu.
Anesthesia and hemodynamic monitoring. Anesthesia
was induced with ketamine hydrochloride (10 mg/kg admin-
istered intramuscularly) and midazolam (1 mg/kg adminis-
tered intramuscularly), and muscular paralysis was main-
tained with pancuronium bromide (0.1 mg/kg administered
intravenously). After endotracheal intubation, the animals
were maintained on positive-pressure ventilation with 35%
oxygen; anesthesia was maintained with isoflurane (1.1%-
1.2%). The arterial catheter was positioned in the left femoral
artery. A thermodilution catheter (CritiCath, 7F; Ohmeda
GmbH & Co, Erlangen, Germany) was placed through the
femoral vein to allow blood sampling, pressure monitoring in
the pulmonary artery, and recording of cardiac output. The
intracranial temperature probe was placed through a drill hole
in the epidural space and was isolated with bone wax. The
drill hole was positioned 1 cm to the right from a sagittal joint
above a parietal line. Other temperature probes were placed
in the esophagus and rectum, and a 10F nelaton catheter was
placed in the urinary bladder to monitor urine output.
Electroencephalographic monitoring. Cortical electrical
activity was registered from 4 stainless steel screw electrodes
(5 mm in diameter) implanted in the skull over the parietal
and frontal areas of the cortex by using a digital electroen-
cephalography (EEG) recorder (Nervus, Reykjavik, Iceland)
and an amplifier (Magnus EEG 32/8, Reykjavik, Iceland).
Sampling frequency was 1024 Hz, and bandwidth was 0.03 to
256 Hz. All EEG recordings are referenced to a frontal screw
electrode, which, together with a ground screw electrode, is
implanted over the frontal sinuses. The recordings were made
by digital EEG, with sensitivity on screen set at 70 µV/cm.
Isoflurane level was adjusted so that EEG showed a steady
burst suppression pattern. After this, isoflurane end tidal con-
centration was kept at this steady level until the end of mon-
itoring. EEG was recorded for 10 minutes to get a baseline
recording of steady burst suppression activity before the cool-
ing period. After HCA, EEG recording was restarted and con-
tinued until the first postoperative day. The durations of EEG
were measured from 5-minute EEG samples at fixed time
points, first with half-hour intervals and later with 1-hour
intervals. From each 5-minute sample, artifact periods were
excluded, and from the rest, the sum of bursts was counted as
a percentage of the sum of artifact-free bursts and suppres-
sions. This percentage was used as a measure of EEG activi-
ty in the analysis.
CPB. Through a right thoracotomy in the fourth intercostal
space, the right thoracic artery was ligated, and the heart and
great vessels were exposed. A membrane oxygenator
(Midiflow D 705; Dideco, Mirandola, Italy) was primed with
1 L of Ringer´s acetate and heparin (5000 IU). After
heparinization (300 IU/kg), the ascending aorta was cannu-
lated with a 16F arterial cannula, and the right atrial
appendage was cannulated with a single 24F atrial cannula.
Nonpulsatile CPB was initiated at a flow rate of 100 mL/kg
per minute, and afterward, the flow was adjusted to maintain
a perfusion pressure of 50 mm Hg. A 12F intracardial sump
cannula was positioned in the left ventricle for decompres-
sion of the left heart during CPB. In a randomly assigned
group an L-DF (Leukoguard LG6, Pall Biomedical) was used
during CPB. A heat exchanger was used for core cooling. The
pH was maintained with alpha-stat principles at 7.40 ± 0.05
with an arterial PCO2 of 4.0 to 5.0 kPa, uncorrected for tem-
perature. All measurements were performed at 37°C.
The cooling period of 60 minutes was carried out to attain
a rectal temperature of 20°C. Cardiac arrest was induced by
injecting potassium chloride (1 mEq/kg) into the aortic can-
nula, and topical cardiac cooling was then maintained
throughout the aortic crossclamp period. The ascending aorta
was crossclamped just proximal to the aortic cannula.
Experimental protocol. After cooling to a rectal temperature
of 20°C and crossclamping of the aorta, the animals underwent
a 75-minute period of HCA with the head packed in ice. After
this 75-minute period, antegrade CPB rewarming was initiated.
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The left ventricular vent cannula was removed. Weaning from
CPB occurred approximately 60 minutes after the start of
rewarming with administration of furosemide (40 mg), manni-
tol (15.0 g), methylprednisolone (80 mg), and lidocaine
(40–150 mg). Cardiac support was provided with dopamine.
Animals were kept in isoflurane anesthesia until the following
morning, extubated, and moved into a recovery room.
During the experiments, hemodynamic and metabolic mea-
surements were recorded at 5 different time points as follows:
at baseline; at the end of cooling (at 20°C, immediately
before HCA); during rewarming (at 30°C); 2 hours after the
start of rewarming; and 4 hours after the start of rewarming.
Postoperative evaluation. Postoperatively, all the ani-
mals were evaluated daily by an experienced observer who
was blinded to the study group by using a species-specific
quantitative behavioral score, as reported earlier.16 The
assessment quantified mental status (0, comatose; 1, stu-
porous; 2, depressed; and 3, normal), appetite (0, refuses
liquids; 1, refuses solids; 2, decreased; and 3, normal), and
motor function (0, unable to stand; 1, unable to walk; 2,
unsteady gait; and 3, normal). Numerical summing of these
functions provides a final score: the maximum (score of 9)
reflects apparently normal neurologic function, and lower
values indicate substantial neurologic damage. A score of 8
means that the animals were able to stand unassisted and
were likely to recover fully. Each surviving animal was
electively put to death on day 7 after the operation. The
entire brain was immediately harvested and weighed for
subsequent histologic analysis.
Histopathologic analysis. During autopsy, the brain was
excised immediately, and the hemispheres were separated.
One half was immersed in 10% neutral formalin and allowed
to fix for 2 weeks en bloc. Thereafter, 3-mm thick coronal
samples were sliced from the frontal lobe, thalamus (includ-
ing the adjacent cortex), and hippocampus (including the adja-
cent brain stem and temporal cortex), and sagittal samples
were sliced from the posterior brain stem (medulla oblongata
and pons) and cerebellum. The pieces were fixed in fresh for-
malin for another week. After the fixation, the samples were
processed as follows: rinsing in water for 20 minutes; immer-
sion in 70% ethanol for 2 hours; immersion in 94% ethanol for
4 hours; and immersion in absolute ethanol for 9 hours.
Thereafter, the pieces were kept for 1 hour in absolute ethanol-
xylene mixture and 4 hours in xylene and embedded in warm
paraffin for 6 hours. The samples were sectioned at 6 µm and
stained with hematoxylin and eosin. The sections of the brain
samples of each animal were screened by a single experienced
senior pathologist (J.H.) unaware of the experimental design
and of the identity and fate of individual animals. Each section
was carefully investigated for the presence or absence of any
hypoxic or other damage.
Visual estimation of the injuries in the sampled regions was
made as follows: 0, no morphologic damage; 1, edema or
eosinophilic dark neurons or dark-shrunk cerebellar Purkinje
cells; 2, at least mild hemorrhage; and 3, clearly infarctive
foci. Total score is the sum of scores in each specific brain
area (cortex, thalamus, hippocampus, posterior brain stem,
and brain stem). To allow semiquantitative comparisons
between the animals, we calculated a total histologic score by
adding all the regional scores. A score of greater than 4
means that the animal had a distinct brain injury.
Serum S-100β. Serum S-100β levels were determined
from mixed venous blood samples by use of a luminescence
immunoassay kit (Sangtec-100, LIA-mat; Sangtec Medical
AB, Bromma, Sweden). Serum S-100β protein levels were
measured at baseline, end of cooling, and 30 minutes, 2
hours, 4 hours, 7 hours, and 20 hours after the start of
rewarming.
Cytokines. Cytokine levels (interleukin [IL] 1β, IL-8, and
tumor necrosis factor [TNF] α) were recorded on the first
postoperative day. Serum specimens were drawn, placed in
aliquots, and stored at –70°C until tested. Cytokine concen-
trations were determined by the enzyme-linked immunosor-
bent assay method according to the manufacturer’s instruc-
tions. Enzyme-linked immunosorbent assay kits (Cytoscreen)
for swine IL-1β, IL-8, and TNF-α were obtained from
Biosource International (Camarillo, Calif). Lower detection
limits for the tests were 15 pg/mL for IL-1β, 10 pg/mL for
IL-8, and 6 pg/mL for TNF-α.
Other measurements. Systemic arterial and venous blood
samples were obtained to determine pH, oxygen tension, car-
bon dioxide tension, oxygen saturation, oxygen content,
hematocrit, hemoglobin, and glucose (Ciba-Corning 288
Blood Gas System; Ciba-Corning Diagnostic Corp,
Medfield, Mass). Lactate was analyzed by means of a YSI
1500 analyzer (Yellow Springs Instrument Co, Yellow
Springs, Ohio). Leukocyte count was done with a Cell-Dyn
analyzer (Abbott, Santa Clara, Calif). Temperatures were
recorded at intervals throughout the study. Hemodynamics,
temperatures, and respiratory gases were monitored by the
Datex AS/3 anesthesia monitor (Datex Inc, Espoo, Finland).
Statistical analysis. Summary statistics for continuous or
ordinal variables are expressed as the median with interquar-
tile range (25th and 75th percentiles) or means with SD.
The analysis was performed by analysis of variance for
repeated measurements. Comparison between relevant time
points and baseline (reference category) was performed by
the paired-sample t test or the Wilcoxon matched pairs signed
rank test. Differences between groups were determined by
means of t tests or the Mann-Whitney U test. Sidák inequali-
ty was used to control the multiple comparison problem.
Analyses were performed by a standard commercially avail-
able statistical program (SPSS version 9.0; SPSS Inc,
Chicago, Ill).
Results
Physiologic data 
Comparability of experimental groups. The mean ± SD
weight of the animals was the same in both of the
groups (26 ± 2 kg). The mean ± SD total CPB time was
131 ± 12 minutes in the L-DF group and 138 ± 10 min-
utes in the control animals. The difference was not sta-
tistically significant (P = .19). The mean ± SD CPB
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cooling time group was 61 ± 10 minutes in the L-DF
group and 65 ± 6 minutes in the control group.
Rewarming times were 70 ± 7 minutes and 74 ± 12
minutes, respectively. Temperatures during the experi-
ment period did not differ between the groups (Fig 1).
Hemodynamic data. All animals were stable before,
during, and after CPB. As seen in Table I, both groups
had a significant decrease in mean arterial pressure
compared with baseline values during rewarming at
30°C at 2 hours after the start of rewarming (P = .001)
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Fig 1. Epidural temperatures of 20 pigs undergoing CPB with or without an L-DF before and after a 75-minute
period of HCA. Values are shown as medians with interquartile range.
Table I. Hemodynamic data, blood gases, and hematocrit levels in 20 pigs undergoing CPB with or without an 
L-DF before and after 75-minute period of HCA
Baseline  End of CPB After start of rewarming
Group N (37°C) cooling (20°C) 30°C 2 h 4 h
MAP (mm Hg)
L-DF 10 75 (70-82) 51 (50-52)† 57 (54-69)† 62 (60-66)†§ 66 (63-70)*
Control 10 78 (75-85) 50 (50-56)† 55 (54-60)† 57 (50-61)† 63 (58-65)*
Cardiac output/CPB flow (L/min)
L-DF 10 3.3 (3.2-3.7) 2.4 (2.2-2.6)* 2.9 (2.5-3.0) 3.5 (3.1-3.8) 2.7 (2.6-3.1)
Control 10 3.5 (3.2-3.8) 2.7 (2.5-2.9)* 2.9 (2.4-3.1)* 3.5 (3.3-4.3) 3.5 (3.3-3.8)
Vascular resistance (dyne × s × cm–5)
L-DF 10 1711 (1353-1956) 1587 (1476-1747) 1634 (1350-1806) 1370 (1191-1500)§ 1851 (1569-2088)
Control 10 1729 (1586-1773) 1486 (1185-1762) 1582 (1371-1771) 1113 (842-1240)‡ 1218 (1173-1354)*
Arterial pH
L-DF 10 7.5 (7.5-7.5) 7.3 (7.3-7.4)* 7.4 (7.3-7.4) 7.3 (7.3-7.4)† 7.4 (7.4-7.5)
Control 10 7.5 (7.5-7.5) 7.3 (7.3-7.3)† 7.5 (7.4-7.5) 7.4 (7.3-7.4)* 7.5 (7.5-7.5)
PaCO2 (mm Hg)
L-DF 10 6.4 (5.9-6.4) 7.4 (6.2-7.9) 5.5 (5.1-6.0) 6.4 (6.3-6.6) 6.9 (6.5-7.0)*
Control 10 5.9 (5.7-6.2) 7.9 (7.2-8.3)† 5.2 (4.9-6.0) 6.1 (6.0-6.2) 6.5 (6.0-6.6)
Hematocrit
L-DF 10 27.2 (25.5-29.9) 17.0 (15.5-17.6)† 17.6 (16.5-18.8)† 23.1 (22.0-26.4)† 23.8 (21.8-25.5)†
Control 10 28.2 (26.8-30.9) 18.8 (18.2-19.0)† 21.0 (19.6-22.1)* 25.5 (24.1-26.8) 26.3 (25.9-27.4)
Values are shown as medians with interquartile range.
MAP, Mean arterial pressure; PaCO2, arterial carbon dioxide tension.
*P < .05, †P < .01, and ‡P < .001 compared with baseline.
§P < .05 and P < .01 between groups.
and 4 hours after the start of rewarming (P < .01).
Mean arterial pressure was higher in the L-DF group 2
hours after the start of rewarming (P < .01), and cardiac
output was higher in control animals 4 hours after the
start of rewarming (P < .01, Table I). Vascular resis-
tance decreased significantly in control animals com-
pared with baseline values 2 hours after the start of
rewarming (P < .001) and 4 hours after the start of
rewarming (P < .01). Vascular resistance was signifi-
cantly higher at the same time points in the L-DF group
(P < .05 and P < .01, Table I).
Blood gas and hematocrit measurements are shown
in Table I. Both groups had a significant decrease in
pH at the end of cooling and 2 hours after the start of
rewarming compared with baseline values (P < .01),
but no significant differences between the groups
were seen. Arterial PCO2 was higher in the control
group at the end of cooling (P < .001) compared with
baseline. In the L-DF group, arterial PCO2 was higher
4 hours after the start of rewarming (P < .01), but no
significant differences between the groups were
detected. The hematocrit level was lower at all time
points compared with baseline in the L-DF group (P
< .001) and at the end of cooling and during rewarm-
ing at 30°C in control animals (P < .01). The hemat-
ocrit level was found to be lower in the L-DF group
than in control animals at the end of cooling and dur-
ing rewarming at 30°C (P < .01).
Metabolic data. The venous lactate increased signif-
icantly during cooling and especially after HCA in both
groups (P < .001). Oxygen consumption decreased sig-
nificantly in both groups during cooling (P < .05).
There were no significant changes in the oxygen
extraction during the experiment (Table II).
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Table II. Venous lactate levels, oxygen extraction, and oxygen consumption during the experiment in 20 pigs
undergoing CPB with or without an L-DF before and after 75-minute period of HCA
Baseline End  of CPB After start of rewarming
Group N (37°C) cooling (20°C) 30°C 2 h 4 h
Venous lactate (mmol/L)
L-DF 10 1.0 (0.9-1.2) 1.9 (1.8-2.1)‡ 6.0 (5.4-6.7)‡ 4.5 (2.7-5.8)‡ 2.4 (1.7-2.9)‡
Control 10 1.0 (0.8-1.0) 1.5 (1.2-2.0)‡ 5.3 (5.0-5.7)‡ 3.9 (3.5-4.8)‡ 1.7 (1.5-2.0)‡
O2 extraction (mmol/L)
L-DF 10 2.5 (2.4-2.6) 1.7 (1.6-1.8) 3.2 (3.0-3.5) 2.6 (2.2-2.9) 3.1 (2.6-3.6)
Control 10 2.5 (2.1-2.8) 1.6 (1.3-1.8) 3.4 (2.2-2.7) 2.5 (2.2-2.7) 2.6 (2.3-2.8)
O2 consumption (mL/min)
L-DF 10 91.0 (80.8-93.5) 39.1 (36.4-50.4)† 83.3 (78.2-105.1) 98.7 (80.7-111.4) 95.6 (80.5-101.7)
Control 10 90.4 (70.2-110.5) 45.1 (34.2-52.0)* 87.6 (66.7-98.4) 95.0 (81.7-106.6) 84.5 (81.3-99.5)
Values are shown as medians with interquartile range.
*P < .05, †P < .01, and ‡P < .001 compared with baseline.
Table III. Leukocyte counts in 20 pigs undergoing CPB with or without an L-DF before and after 75-minute period
of HCA
Baseline End of CPB After start of rewarming
Group N (37°C) cooling (20°C) 30°C 2 h 4 h
WBC (×109/L)
L-DF 10 18.4 (14.6-20.9) 3.6 (1.7-4.3)‡ 3.6 (2.1- 4.7)‡§ 6.8 (4.6-12.1)† 16.0 (13.5-21.0)
Control 10 19.1 (13.8-20.6) 4.0 (2.9-5.2)‡ 4.4 (3.8- 6.2)‡ 6.0 (4.1-15.5)† 16.5 (12.7-23.9)
Neutrophils (×109/L)
L-DF 10 9.2 (6.01-12.0) 1.7 (0.8-2.6)* 1.7 (1.0-2.2)* 3.8 (1.0-8.1) 12.3 (10.3-16.0)
Control 10 9.5 (5.8-9.8) 2.1 (1.6-2.8)* 1.6 (1.5-2.9)* 2.9 (1.8-10.0) 12.7 (10.1-20.2)
Lymphocytes (×109/L)
L-DF 10 8.2 (7.9-9.2) 1.4 (0.9- 1.9)‡ 1.8 (1.2-2.3)‡ 3.2 (2.9-3.6)‡ 3.3 (2.8-3.6)‡
Control 10 9.0 (7.9-10.5) 2.0 (1.7-2.3)‡ 2.7 (2.2-3.4)‡ 3.4 (2.6-3.7)‡ 3.2 (2.6-3.6)‡
Values are shown as medians with interquartile range. WBC, White blood cell counts.
*P < .05, †P < .01, and ‡P < .001 compared with baseline.
§P = .069 and P = .016 between the groups.
Leukocyte count. White blood cell count decreased
significantly during cooling and after intervention in
both groups (P < .01) and tended to be lower in the L-
DF group during rewarming at 30°C (P = .07).
Neutrophil count decreased significantly during cool-
ing and rewarming in both groups (P < .05).
Lymphocyte count decreased significantly during cool-
ing and after intervention in both groups (P < .001) and
was lower in the L-DF group during rewarming at 30°C
(P = .02, Table III).
EEG. No statistically significant differences between
groups in the rate of EEG burst recovery was detected.
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Fig 2. EEG burst recovery of 20 pigs undergoing CPB with or without an L-DF before and after a 75-minute peri-
od of HCA. Bold lines indicate medians, and broken lines depict animals with early mortality.
Fig 3. Daily scores indicating behavioral recovery of 20 pigs undergoing CPB with or without an L-DF before and
after a 75-minute period of HCA. A score of 8 or 9 indicates essentially complete recovery; lower scores indicate
substantial impairment, and 0 indicates coma or death. P values are given for the difference between groups in score
by time.
EEG did not recover to a recordable level in one con-
trol pig. In one pig of the control group, EEG burst dis-
appeared at 12 hours, and in one pig of the L-DF group,
burst disappeared at 14 hours (Fig 2).
Morbidity and mortality. All animals were in stable
condition during the surgical procedures and survived at
least to the first postoperative day. Thirteen (65%) of the
20 animals survived 7 days after the operation and were
electively put to death. In the L-DF group 8 (80%) of 10
animals survived for 7 days compared with 5 (50%) of 10
animals in the control group. The risk for early death in
control animals was 2.5 (95% confidence interval, 0.63-
10) times higher than that of animals in the L-DF group.
Behavioral outcome. The results of behavioral scor-
ing for both groups are shown in Fig 3. A score of 8 or
9 indicates an essentially complete neurologic recov-
ery. Animals that died early were given a score of zero
beginning at the time of death. The median behavioral
score at day 7 was higher in the L-DF group (8.5 vs 3.5;
P = .04). The median behavioral score at day 7 among
the surviving animals was 9 in the L-DF group and 8 in
the control animals (P = .08).
Histopathologic results. In terms of histopathology,
better outcomes were found in all 5 studied brain
regions in the L-DF group than in the control group
(Table IV). The total histopathologic score was calcu-
lated by adding the quantitative assessment of
histopathologic findings in the investigated regions of
the brain for each of the animals. The median of total
histopathologic scores was 8.5 in the L-DF group and
15.5 in the control group (P = .005). As seen in Fig 4,
the total score tended to be higher in animals with early
death compared with animals surviving 7 days (P =
.13). The median of total histopathologic score among
surviving animals was 6.5 in the L-DF group and 14 in
the control group (P = .08).
Cytokines. TNF-α levels increased after intervention
in both groups. The medians of TNF-α levels in the L-
DF group was 18 pg/mL at 30°C during rewarming and
107 pg/mL after 2 hours after the start of rewarming. At
the same time points, medians in the control group were
3 pg/mL and 861 pg/mL. The changes were found to be
statistically significant compared with baseline values (P
< .05), but there were no statistically significant differ-
ences between the groups. IL-1β and IL-8 did not differ
during the experiment between the groups (Table V).
S-100β. S-100β levels increased after intervention in
both groups, being higher compared with baseline val-
ues in the L-DF group during rewarming at 30°C (P =
.03). After this and during rewarming, S-100β levels
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Table IV. Histopathologic scores after the experiment in 20 pigs undergoing a 75-minute period of HCA either
with or without an L-DF 
Protocol Pig No. Cortex Thalamus Hippocampus Posterior brain stem Cerebellum Total score
L-DF group 1 1 0 1 1 3 6
2 3 3 1 3 3 13
3 1 0 0 2 2 5
4 1 0 1 2 1 5
5 4 3 1 1 1 10
6 4 1 1 3 3 12
7 1 1 1 2 0 5
8 4 1 1 3 1 10
9 1 0 1 2 3 7
10 3 2 2 3 3 13
Medians 2 2 1 2 2.5 8.5
Control group 1 4 3 2 3 4 16
2 6 6 4 3 3 22
3 2 1 1 3 3 10
4 1 0 0 0 1 2
5 5 3 3 2 3 16
6 3 1 4 2 3 13
7 7 3 2 2 4 18
8 4 1 2 4 4 15
9 4 6 2 3 3 18
10 4 4 2 3 1 14
Medians 4 3 2 3 3 15.5
P values between groups .004 .026 .001 .025 .015 .005
Scores are defined as follows: 0, no morphologic damage; 1, edema or eosinophilic dark neurons or dark-shrunk cerebellar Purkinje cells; 2, at least mild hemor-
rhage; and 3, clearly infarctive foci. Total score is the sum of scores in each specific brain area (cortex, thalamus, hippocampus, posterior brain stem, and brain stem).
To allow semiquantitative comparisons between the animals, we calculated a total histologic score by adding all the regional scores.
decreased below baseline in the L-DF group, and a sta-
tistically significant difference was seen 4 hours after
the start of rewarming (P = .05). No difference between
the groups was detected (Fig 5).
Discussion
The present data indicate that leukocyte filtration
during CPB improves brain protection after a pro-
longed period of HCA. The differences were seen in
terms of behavioral and histopathologic data. These
findings suggest that leukocyte-depleting filtration mit-
igates reperfusion injury in the brain.
The most frequently used method to protect the brain
during operations on the aortic arch is hypothermia.1
Hypothermia produces a state of decreased oxygen meta-
bolic activity, thereby reducing tissue damage by increas-
ing the length of permissible period of HCA.
Hypothermia specifically prevents the release of neuro-
transmitters and delays the onset of the fatal biochemical
cascade.1,2 The knowledge of biochemical cascade has
opened up new possibilities to improve cerebral protec-
tion against ischemia. We have learned thus far that ener-
gy failure itself is not particularly toxic to neurons. What
makes energy failure neurotoxic is subsequent activation
of glutamate receptor–related mechanisms. If these are
blocked by suitable antagonists, the neurons may survive
over the period when the supply of oxygen and substrate
are compromised. The most studied antagonists are glu-
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Fig 4. Total histopathologic scores of 20 pigs undergoing
CPB with or without an L-DF before and after a 75-minute
period of HCA. The total histopathologic score was calculat-
ed by adding the quantitative assessment of histopathologic
findings in the investigated regions of the brain for each of
the animals. The scores in the L-DF group were lower than
those in the control group (P = .005).
Fig 5. S-100 protein levels of 20 pigs undergoing CPB with
or without an L-DF before and after a 75-minute period of
HCA. Medians with interquartile range are shown. There
were no statistically significant differences between the
groups.
Table V. TNF-α, IL-1β, and IL-8 levels in 20 pigs undergoing CPB with or without an L-DF before and after 75-
minute period of HCA
Baseline End of CPB cooling After start of rewarming
Group N (37°C) (20°C) 30°C 2 h 4 h 7 h 24 h
TNF-α (pg/mL)
L-DF 10 0 (0) 0 (0-5) 18 (0-88)* 107 (4-863)* 0 (0-16) 0 (0-11) 0 (0-9)
Control 10 0 (0) 0 (0-3) 3 (0-9) 851 (9-977)* 5 (0-15) 0 (0-1) 0 (0-1)
IL-1β (pg/mL)
L-DF 10 0 (0-151) 34 (0-195) 28 (0-61) 31 (0-300) 125 (0-280) 1 (0-359) 54 (0-529)
Control 10 0 (0-132) 0 (0-140) 6 (0-117) 5 (0-99) 4 (0-177) 31 (0-127) 0 (0-2,8)
IL-8 (pg/mL)
L-DF 10 0 (0) 0 (0) 0 (0) 0 (0-18) 0 (0) 0 (0) 0 (0)
Control 10 0 (0) 0 (0) 0 (0) 7 (0-78) 0 (0-10) 0 (0) 0 (0)
Values are shown as medians with interquartile range.
*P < .05 compared with baseline values.
tamate receptor blockers and Ca2+ and Na+ channel
antagonists. Many of these antagonists have turned out to
be neurotoxic in a clinical setting.17 We have demonstrat-
ed very recently that the Na+ channel blocker lamotrigine
improves brain protection during HCA.14
The third subsequential phase in ischemic cerebral
injury is reperfusion injury occurring after depolariza-
tion and biochemical cascade. Leukocyte infiltration
and cytokine-mediated inflammatory reaction are
known to play pivotal roles in this phase.4,5 There are
different strategies to mitigate inflammatory injury in
the brain; direct cytokine inhibition is one such strate-
gy. Cytokine inhibition by anti-TNF-α monoclonal
antibodies can reduce focal ischemic injury. Another
possibility is the inhibition of endothelial interactions
with leukocytes (ie, blocking the endothelial side of the
adhesion molecule). The use of antileukocyte treat-
ments is also a potential strategy.6 Heparin has been
used to inhibit leukocyte accumulation in cerebral
ischemia.18 All of these strategies are found to be
promising in the experimental setting.
It has been previously shown that leukocyte depletion
can ameliorate myocardial reperfusion injury.7,8
Leukocyte-depleting filtration is also shown to reduce
ventricular dysfunction during prolonged postischemic
reperfusion9 and to attenuate reperfusion injury in
patients with left ventricular hypertrophy.19 When more
than 3 blood transfusions are required after a cardiac
operation, leukocyte depletion of transfused blood
results in a significant reduction of postoperative mortal-
ity.20 Leukocyte depletion during and after CPB has
been demonstrated to improve pulmonary function10 and
to ameliorate free radical–mediated lung injury.11,12 The
present study is the first attempt to mitigate HCA-relat-
ed brain injury by using leukocyte-depleting filtration.
The hardest data in the present study are undoubted-
ly the histopathology. The total histopathologic score
was significantly lower in the L-DF group, and the dif-
ferences were also seen in all studied regions of the
brain. In line with this was the mortality, with the rate
of early deaths being 5 of 10 in the control group and 2
of 10 in the L-DF group, supporting the favorable
effect of leukocyte filtration after HCA. Because leuko-
cyte filtration is known to mitigate reperfusion in other
tissues, such as the heart and lung, the possibility that
improved outcome was a consequence of better preser-
vation of these organs after perfusion cannot be exclud-
ed. The behavioral outcome was also better in the L-DF
group. Control animals showed more severe initial neu-
rologic impairment, and recovery to score 9 was not
seen. Looking at the overall consistency of all this out-
come data obtained by using this chronic animal model
and the fact that brain was exposed for major injury in
this particular protocol, it is likely that the favorable
effect of leukocyte-depleting filtration is due to better
maintenance of neuronal function. This hypothesis was
supported by the finding that animals with early mor-
tality had higher total histopathologic scores compared
with animals that survived for 7 days (Fig 4). To study
this hypothesis further, we tested the outcomes in the
surviving animals in both groups. In this comparison
histopathologic scores tended to be lower (P = .08) and
behavioral scores tended to be higher (P = .08) in the
L-DF group. These findings give further evidence to
the claim that the beneficial effect of white cell filtra-
tion is a consequence of improved brain protection.
There were no statistically significant differences in
EEG burst recovery. When we studied the Na+ chan-
nel blocker lamotrigine with this same model, we
found that the lamotrigine group had better EEG
recovery after HCA.14 Lamotrigine and other neuro-
protective drugs have an effect on biochemical cas-
cade, and leukocyte-depleting filtration exercises an
effect on reperfusion injury; this can explain the dif-
ference between the studies. In 1 control animal there
were no EEG bursts after HCA, and there were 2 ani-
mals (1 in each group) whose EEG bursts decreased
after earlier recovery. All 3 animals died soon after
extubation. This is in line with other data and supports
the hypothesis that early mortality was due to neuro-
logic damage (Fig 2). EEG was the only method that
could depict the time point when the cerebral cortex
probably died.
White blood cell count decreased during and after
intervention in both groups but returned to baseline
level at 4 hours after the start of rewarming. White
blood cell counts tended to be lower in the L-DF group
shortly after the start of rewarming. Neutrophil levels
were in line with this, but no differences between the
groups were detected. Lymphocyte levels decreased
during and after intervention in both groups, and lym-
phocyte counts did not return to baseline during exper-
iment. The lymphocyte levels tended to be lower in the
L-DF group during rewarming at 30°C. It has been
demonstrated by investigating the expression of anti-
gens on neutrophils that the LG-6 filter selectively
removes activated neutrophils but does not have a sig-
nificant enough effect to reduce the total leukocyte
count.21 This may explain why only marginal differ-
ences between the groups was seen in present study.
TNF-α increased after HCA in both of the study
groups, and the levels tended to be lower in the L-DF
group than in the control group. There were no differ-
ences between groups in IL-1β and IL-8 levels, and the
changes were much smaller compared with baseline
values as concerns TNF-α levels. These findings were
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surprising because TNF-α and IL-1β are shown to play
an important role in brain immune and inflammatory
activities and ischemic brain injury.4-6 On the basis of
current data, we have to admit that the cytokines mea-
sured here might not be the mediators we should be
looking for in this context.
Serum S-100β protein has been suggested to be a
neurobiochemical marker of brain injury after cardiac
and aortic arch operations.22 S-100β release has been
associated with length of HCA.23,24 A recent study has
demonstrated a correlation between early changes in
neuropsychologic performance and S-100β elaboration
after HCA.25 In the present study there were no differ-
ences between the groups in S-100β release. The rea-
son for this remains open. In our previous article study-
ing the use of lamotrigine before HCA, there was a
statistically significant difference between groups in S-
100β release.14 One explanation for this could be the
fact that leukocyte-depleting filtration has an effect on
reperfusion injury and not biochemical cascade.
In conclusion, the present data strongly suggest that
leukocyte-depleting filtration before and after pro-
longed periods of HCA improves brain protection.
We thank Professor Randall B. Griepp, MD, who gener-
ously permitted us to use this animal model; Ville Jäntti, MD,
PhD, for helping in EEG analysis; Heljä-Marja Surcel, MD,
PhD, for cytokine analysis; and Seija Seljänperä, RN, Veikko
Lähteenmäki, and Kauko Korpi, RN, for technical assistance.
R E F E R E N C E S
1. Griepp RB, Ergin MA, McCullough JN, et al. Use of hypother-
mic circulatory arrest for cerebral protection during aortic
surgery. J Card Surg 1997;12(Suppl):312-21.
2. McCullough JN, Zhang N, Reich D, et al. Cerebral metabolic
suppression during hypothermic circulatory arrest in humans.
Ann Thorac Surg 1999;67:1895-9.
3. Lipton SA, Rosenberg PA. Excitatory amino acids as a final com-
mon pathway for neurologic disorders. N Engl J Med
1994;330:613-22.
4. Feuerstein GZ, Liu T, Barone FC. Cytokines, inflammation, and
brain injury: role of tumor necrosis factor-alpha. Cerebrovasc
Brain Metab Rev 1994;6:341-60.
5. Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the
neuropathology of stroke and neurotrauma. Neuroimmunomodu-
lation 1998;5:143-59.
6. Feuerstein G, Wang X, Barone FC. Cytokines in brain
ischemia—the role of TNF alpha. Cell Mol Neurobiol
1998;18:695-701.
7. Lazar HL, Zhang X, Hamasaki T, et al. Role of leukocyte deple-
tion during cardiopulmonary bypass and cardioplegic arrest. Ann
Thorac Surg 1995;60:1745-8.
8. Schmidt FE Jr, MacDonald MJ, Murphy CO, et al. Leukocyte
depletion of blood cardioplegia attenuates reperfusion injury. Ann
Thorac Surg 1996;62:1691-6.
9. Wilson IC, Gardner TJ, DiNatale JM, et al. Temporary leukocyte
depletion reduces ventricular dysfunction during prolonged
postischemic reperfusion. J Thorac Cardiovasc Surg
1993;106:805-10.
10. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte
depletion results in improved lung function and reduced inflam-
matory response after cardiac surgery. J Thorac Cardiovasc Surg
1996;112:494-500.
11. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ame-
liorates free radical–mediated lung injury after cardiopulmonary
bypass. J Thorac Cardiovasc Surg 1990;99:873-7.
12. Bolling KS, Halldorsson A, Allen BS, et al. Prevention of the
hypoxic reoxygenation injury with the use of a leukocyte-deplet-
ing filter. J Thorac Cardiovasc Surg 1997;113:1081-9.
13. Anttila V, Kiviluoma K, Pokela M, et al. Cold retrograde cerebral
perfusion improves cerebral protection during moderate
hypothermic circulatory arrest: a study in a chronic porcine
model. J Thorac Cardiovasc Surg 1999;118:938-45.
14. Anttila V, Rimpiläinen J, Pokela M, et al. Lamotrigine improves
cerebral outcome after hypothermic circulatory arrest: a study
using chronic porcine model. J Thorac Cardiovasc Surg
2000;120:247-55. 
15. Anttila V, Pokela M, Kiviluoma K, et al. Is the maintained cranial
hypothermia the only factor leading to improved outcome fol-
lowing retrograde cerebral perfusion? An experimental study
using a chronic porcine model. J Thorac Cardiovasc Surg
2000;119:1021-9
16. Juvonen T, Weisz DJ, Wolfe D, et al. Can retrograde perfusion
mitigate cerebral injury after particulate embolization? A study in
a chronic porcine model. J Thorac Cardiovasc Surg
1998;115:1142-59.
17. Small DL, Buchan AM. Mechanisms of cerebral ischemia: intra-
cellular cascades and therapeutic interventions. J Cardiothorac
Vasc Anesth 1996;10:139-46.
18. Yanaka K, Spellman SR, McCarthy JB, et al. Reduction of brain
injury using heparin to inhibit leukocyte accumulation in a rat
model of transient focal cerebral ischemia. I. Protective mecha-
nism. J Neurosurg 1996;85:1102-7.
19. Sawa Y, Taniguchi K, Kadoba K, et al. Leukocyte depletion atten-
uates reperfusion injury in patients with left ventricular hypertro-
phy. Circulation 1996;93:1640-6.
20. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial
effects of leukocyte depletion of transfused blood on postopera-
tive complications in patients undergoing cardiac surgery: a ran-
domized clinical trial. Circulation 1998;97:562-8.
21. Thurlow P, Doolan L, Sharp R, et al. Laboratory studies of the
effect of Pall extracorporeal leukocyte filters LG6 and AV6 on
patients undergoing coronary bypass grafts. Perfusion
1996;11:29-37.
22. Westaby S, Johsson P, Parry AJ, et al. S100 protein a potential
marker for cerebral events during cardiopulmonary bypass. Ann
Thorac Surg 1996;61:88-92.
23. Wong CH, Rooney SJ, Bonser RS, et al. S-100 beta release in
hypothermic circulatory arrest and coronary artery surgery. Ann
Thorac Surg 1999;67:1911-4.
24. Bhattarya K, Westaby S, Pillai R, et al. Serum S-100β and
hypothermic circulatory arrest in adults. Ann Thorac Surg
1999;68:1225-9.
25. Svensson LG, Husain A, Penney DL, et al. A prospective ran-
domized study of neurocognitive function and S-100 protein after
antegrade or retrograde brain perfusion with hypothermic arrest
for aortic surgery. J Thorac Cardiovasc Surg 2000;119:163-7.
1140 Rimpiläinen et al The Journal of Thoracic and
Cardiovascular Surgery
December 2000
